Silica-Coated Quantum Dot Nanoparticles for Renal Clearance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current fluorescent nanoparticles for cancer detection and treatment are limited by their stability, brightness, and toxicity, as well as their inability to effectively target and image tumors due to their large size and low specificity.
Innovation Solution
Development of fluorescent silica-based nanoparticles with a silica core and a conducting shell, coated with organic polymers like PEG, which are designed to be small enough for renal clearance, non-toxic, and capable of binding tumor-specific ligands and therapeutic agents, allowing for precise targeting and imaging of cancer cells using various imaging modalities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Length of moving object
If conventional fluorophores (organic dyes, fluorescent proteins) are used, then the nanoparticle can be made small for renal clearance, but the fluorescence stability and brightness are limited due to photobleaching and excited state interactions
Solution Approach 1:
The patent uses semiconductor quantum dots as fluorescent cores, which are synthetic copies that replicate and enhance the desirable properties of conventional fluorophores while eliminating their weaknesses. Q-dots provide superior photostability and brightness compared to organic dyes and fluorescent proteins, solving the reliability issue while maintaining the small size needed for renal clearance.
Solution Approach 2:
The patent creates a composite nanoparticle structure with a semiconductor quantum dot core and a silica shell. This composite design combines the excellent fluorescent properties of Q-dots with the biocompatibility and stability of silica, achieving both high fluorescence reliability and appropriate size for renal clearance.
2Illumination intensity
If semiconductor quantum dots are used for enhanced brightness, then the fluorescent efficiency is improved, but the toxicity increases due to heavy metal ions
Solution Approach 1:
The patent introduces a silica shell as an intermediary layer between the toxic semiconductor quantum dot core and the biological environment. This silica coating acts as a protective barrier that prevents direct contact between the heavy metal ions and biological tissues, thereby eliminating toxicity while preserving the high brightness of the Q-dot core.
Solution Approach 2:
The patent converts the potentially harmful heavy metal core into a beneficial high-brightness fluorescent source by enclosing it within a biocompatible silica shell. The harmful heavy metals are transformed into a useful component that provides superior fluorescence when properly isolated, turning a liability into an asset.
3Adaptability or versatility
If larger particle probes are used, then the nanoparticle can carry multiple functionalities, but the renal clearance is reduced and RES uptake increases
Solution Approach 1:
The patent employs a nested structure where the fluorescent quantum dot core is enclosed within a silica shell, and both are coated with PEG and functionalized with targeting ligands. This nested design allows multiple functionalities (fluorescence, targeting, stability) to be integrated within a compact size that maintains renal clearance efficiency.
Solution Approach 2:
The patent uses a thin silica shell and PEG coating that provide structural integrity and functional versatility without significantly increasing particle size. This flexible shell approach enables multiple functionalities while maintaining the small size necessary for efficient renal clearance.
4Measurement precision
If the nanoparticle is functionalized with targeting ligands, then the tumor specificity is improved, but the device complexity increases
Solution Approach 1:
The patent applies local quality by functionalizing only the outer surface of the nanoparticle with targeting ligands while keeping the core structure simple. The silica shell and PEG coating provide a localized platform for ligand attachment, enabling specific tumor targeting without complicating the overall nanoparticle architecture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These nanoparticles exhibit enhanced photostability, specificity, and accumulation in tumors, enabling effective detection and treatment of cancer with minimal side effects and rapid renal clearance, reducing the risk of toxicity and improving diagnostic accuracy.
Implementation Method 1
a silica-based core comprising a fluorescent compound positioned within the silica-based core
Data Source
AI summary
The present invention provides a fluorescent silica-based nanoparticle that allows for precise detection, characterization, monitoring and treatment of a disease such as cancer. The nanoparticle has a range of diameters including between about 0.1 nm and about 100 nm, between about 0.5 nm and about 50 nm, between about 1 nm and about 25 nm, between about 1 nm and about 15 nm, or between about 1 nm and about 8 nm. The nanoparticle has a fluorescent compound positioned within the nanoparticle, and has greater brightness and fluorescent quantum yield than the free fluorescent compound. The nanoparticle also exhibits high biostability and biocompatibility. To facilitate efficient urinary excretion of the nanoparticle, it may be coated with an organic polymer, such as poly(ethylene glycol) (PEG). The small size of the nanoparticle, the silica base and the organic polymer coating minimizes the toxicity of the nanoparticle when administered in vivo. In order to target a specific cell type, the nanoparticle may further be conjugated to a ligand, which is capable of binding to a cellular component associated with the specific cell type, such as a tumor marker. In one embodiment, a therapeutic agent may be attached to the nanoparticle. To permit the nanoparticle to be detectable by not only optical fluorescence imaging, but also other imaging techniques, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), computerized tomography (CT), bioluminescence imaging, and magnetic resonance imaging (MRI), radionuclides/radiometals or paramagnetic ions may be conjugated to the nanoparticle.